Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Utkarsh Pandey: Japan Approves Wayrilz for ITP Patients
Jun 28, 2026, 09:55

Utkarsh Pandey: Japan Approves Wayrilz for ITP Patients

Utkarsh Pandey, Principal Study Data Manager Leader at Sanofi, shared a post on LinkedIn:

“Exciting news!

Wayrilz (rilzabrutinib) has received approval in Japan for the treatment of immune thrombocytopenia (ITP).

This approval is supported by the LUNA 3 phase 3 study, which demonstrated rapid and durable platelet response. It is a significant milestone for patients managing this rare, complex immune disease.”

Stay updated with Hemostasis Today.